trial
as of 2026-07-01Antipsychotic Polypharmacy: Prevalence, Background and Consequences
NCTId NCT00541398
at a glance
— · Completed
Enrollment 222 (estimated)
Sponsored by Glostrup University Hospital, Copenhagen
Primary completion 2009-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
222 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2008-01
Primary completion
2009-01
Eligibility
ALL · 18 Years · 64 Years
Interventions & indications
Indications
Sponsors
Glostrup University Hospital, CopenhagenLead Sponsor
National Board of Health, DenmarkCollaborator
Investigators
1
Birte Glenthøj, ProfessorStudy Director
Sites
1 total
Glostrup Municipality, Denmark
Facts & assertions
4 sourced
Enrollment
222
Phase
NA
Primary Completion Date
2009-01
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
indication
indication
investigator